You can't rely on whytee to provide any specific information.He treats requests for more information like he is being interrogated.
Fortunately for us MSB has provided responses that have are initially assessed as complete by the FDA.
Whytee McStuffin's concerns are currently irrelevant. Who knows, that might change if another CRL is issued, but there is currently no public information to suggest that is the case.Their irrelevant musings are just biased opinions and assumptions.
Cell Therapy News/Articles, page-16466
-
- There are more pages in this discussion • 1,321 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |